Wishing you all the joys of the season! 
Europe Vitamin K2 Market Forecast to 2030
Europe Vitamin K2 Market Forecast to 2030 – Regional Analysis – by Product (MK-4, MK-7, and Combination Drugs), Dosage Forms (Capsules & Tablets, Powder, and Oils), Source (Natural and Synthetic), and Application (Pharmaceuticals, Nutraceuticals and Food, and Others)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Growing Cases of Osteoporosis Bone Deformation in Adults and Newborns Fuels Europe Vitamin K2 Market
Osteoporosis is an increasingly common health issue affecting adults and babies, a disorder marked by weakening and fragile bones. According to International Osteoporosis Foundation 2022, globally osteoporosis causes more than 8.9 million fractures every year resulting in osteoporotic fracture in every 3 seconds. Medical professionals are concerned about the surge in osteoporosis-related bone distortion cases. As per recent studies from Research Gate, the potential advantages of vitamin K2 include supporting bone health and possibly reducing the consequences of osteoporosis.
Vitamin K2 is a lesser-known vitamin K essential for maintaining healthy calcium metabolism and bone density. It stimulates proteins that transfer calcium from the bloodstream into the bones to ensure adequate mineralization and strength. The nutrient aid in avoiding osteoporosis-related bone fractures and deformities by improving calcium absorption. Adult osteoporosis cases frequently result from hormonal changes, age-related bone loss, or inadequate food intake. Vitamin K2 supplementation has demonstrated promising outcomes in enhancing bone mineral density and lowering fracture risk among adults. In addition, women are the main target for bone health products due to their higher incidence of osteoporosis. The increasing incidence of osteoporosis-related difficulties continues to be a key focus for functional foods and supplements such as calcium and vitamin D are the primary components supporting bone health. Calcium is the main mineral component of bones, while vitamin helps with calcium absorption. changes However, as consumers are becoming more aware of the benefits of vitamin K2, its availability in foods and supplements is rising. In addition, it has been proposed that vitamin K2 aids in reducing the activity of osteoclast cells, which are responsible for bone deterioration, further protecting bone integrity.
Newborns can develop osteoporosis, especially preterm babies. They are more prone to fractures since their bones are immature and weak. Vitamin K2 improves bone growth and lessens the likelihood of bone abnormalities in the therapy regimens for these infants. Their skeletal development is accelerated by vitamin K2 supplementation, which supports the naturally occurring processes during the early stages of life. Thus, the growing number of adult and neonatal incidences of osteoporosis-related bone abnormalities creates the urgent need for efficient preventative measures and treatment approaches. Hence, vitamin K2 supplementation acts as a potential supplementary therapy that helps with calcium metabolism, bone mineralization, and the prevention of fractures. All these factors are driving the market growth.
Europe Vitamin K2 Market Overview
The Europe vitamin K2 market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The growth of the market is attributed to the increasing prevalence of CVD and growing cases of osteoporosis bone deformation in adults and newborns. However, the limited awareness regarding benefits of vitamin K2 hinders the market growth. Countries such as Germany and Italy are expected to be the most significant contributors to market growth in the region and countries such as France, the UK, and Spain are likely to have growth opportunities for vitamin K2. The European vitamin K2 market is expected to grow owing to the surge in non-invasive aesthetic treatments such as non-surgical skin tightening and non-surgical fat reductions due to increased awareness of aesthetic appearance. Furthermore, the medical devices industry developments and the rising numbers of aesthetic clinics may offer vital growth opportunities.
Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Million)
Europe Vitamin K2 Market Segmentation
The Europe vitamin K2 market is segmented into product, dosage forms, source, application, and country.
Based on product, the Europe vitamin K2 market is segmented into MK-4, MK-7, and combination drugs. The MK-7 segment held the largest share of the Europe vitamin K2 market in 2022.
Based on dosage forms, the Europe vitamin K2 market is segmented into capsules & tablets, powder, and oils. The powder segment held the largest share of the Europe vitamin K2 market in 2022.
Based on source, the Europe vitamin K2 market is segmented into natural and synthetic. The natural segment held a larger share of the Europe vitamin K2 market in 2022.
Based on application, the Europe vitamin K2 market is segmented into pharmaceuticals, nutraceuticals and food, and others. The pharmaceuticals segment held the largest share of the Europe vitamin K2 market in 2022.
Based on country, the Europe vitamin K2 market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe vitamin K2 market in 2022.
Anderson Global Group LLC, Balchem Corp, BASF SE, Glanbia Plc, International Flavors & Fragrances Inc, Koninklijke DSM NV, Lesaffre et Cie SA, Lonza Group AG, and Novozymes AS are some of the leading companies operating in the Europe vitamin K2 market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team’ research, the Europe vitamin K2 market was valued at US$ 53.27 million in 2022 and is expected to reach US$ 423.10 million by 2030, registering a CAGR of 29.6% from 2022 to 2030. Regulatory consideration and standards and expansion of distribution channel are among the critical factors attributed to the Europe vitamin K2 market expansion.
Expanding the distribution channels for vitamin K2 can help improve the accessibility of this essential nutrient to a broader population. To effectively expand the distribution channels for vitamin K2, it is necessary to collaborate with various stakeholders-including manufacturers, wholesalers, retailers, and online platforms. Working closely with manufacturers ensures increased production and supply of vitamin K2 products to meet the growing demand. The distribution of these items to merchants in pharmacies, health shops, supermarkets, and specialty supplement stores, can be made easier by forming relationships with wholesalers. Additionally, customers can be made aware of the value of vitamin K2 by viewing product displays and educational materials at retail locations. Also, it is critical to work with developing economies-based e-commerce companies and web-based platforms to provide customers with a simple way to buy supplements and other items containing vitamin K2 online.
Furthermore, encouraging the inclusion of vitamin K2 in everyday meals and drinks can broaden the market for supplements, making it more available to people preferring a nutritional diet. Working with healthcare experts such as doctors, nutritionists, and dietitians is also essential, as these experts can advise patients to take vitamin K2 supplements and recommend a store to buy the product. This is raising the demand for vitamin K2. Thus, the expansion of the distribution networks through medical channels is expected to provide ample opportunities for market growth in the coming years.
On the contrary, limited awareness regarding benefits of vitamin K2 hampers the Europe vitamin K2 market.
Based on product, the Europe vitamin K2 market is segmented into MK-4, MK-7, and combination drugs. The MK-7 segment held 64.3% share of Europe vitamin K2 market in 2022, amassing US$ 34.26 million. It is projected to garner US$ 276.94 million by 2030 to expand at 29.9% CAGR during 2022-2030.
Based on dosage forms, the Europe vitamin K2 market is segmented into capsules & tablets, powder, and oils. The powder segment held 56.5% share of Europe vitamin K2 market in 2022, amassing US$ 30.11 million. It is projected to garner US$ 247.44 million by 2030 to expand at 30.1% CAGR during 2022-2030.
Based on source, the Europe vitamin K2 market is segmented into natural and synthetic. The natural segment held 83.6% share of Europe vitamin K2 market in 2022, amassing US$ 44.54 million. It is projected to garner US$ 357.07 million by 2030 to expand at 29.7% CAGR during 2022-2030.
Based on application, the Europe vitamin K2 market is segmented into pharmaceuticals, nutraceuticals and food, and others. The pharmaceuticals segment held 67.0% share of Europe vitamin K2 market in 2022, amassing US$ 35.68 million. It is projected to garner US$ 277.57 million by 2030 to expand at 29.2% CAGR during 2022-2030.
Based on country, the Europe vitamin K2 market has been categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 29.3% share of Europe vitamin K2 market in 2022. It was assessed at US$ 15.60 million in 2022 and is likely to hit US$ 120.88 million by 2030, exhibiting a CAGR of 29.2% during 2022-2030.
Key players operating in the Europe vitamin K2 market are Anderson Global Group LLC, Balchem Corp, BASF SE, Glanbia Plc, International Flavors & Fragrances Inc, Koninklijke DSM NV, Lesaffre et Cie SA, Lonza Group AG, and Novozymes AS, among others.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Europe Vitamin K2 Market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Vitamin K2 Market – Key Industry Dynamics
4.1 Key Market Drivers:
4.1.1 Increasing Prevalence of CVD
4.1.2 Growing Cases of Osteoporosis Bone Deformation in Adults and Newborns
4.2 Market Restraints
4.2.1 Limited Awareness Regarding Benefits of Vitamin K2
4.3 Market Opportunities
4.3.1 Expansion of Distribution Channel
4.4 Future Trends
4.4.1 Regulatory Consideration and Standards
4.5 Impact Analysis:
5. Vitamin K2 Market – Europe Market Analysis
5.1 Europe Vitamin K2 Market Revenue (US$ Mn), 2022 – 2030
6. Europe Vitamin K2 Market – Revenue and Forecast to 2030 – by Product.
6.1 Overview
6.2 Europe Vitamin K2 Market Revenue Share, by Product 2022 & 2030 (%)
6.3 MK-4
6.3.1 Overview
6.3.2 MK-4: Europe Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
6.4 MK-7
6.4.1 Overview
6.4.2 MK-7: Europe Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Combination Drugs
6.5.1 Overview
6.5.2 Combination Drugs: Europe Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
7. Europe Vitamin K2 Market – Revenue and Forecast to 2030 – by Dosage Form.
7.1 Overview
7.2 Europe Vitamin K2 Market Revenue Share, by Dosage Form, 2022 & 2030 (%)
7.3 Capsules and Tablets
7.3.1 Overview
7.3.2 Capsules and Tablets: Europe Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Powder
7.4.1 Overview
7.4.2 Powder: Europe Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Oil
7.5.1 Overview
7.5.2 Oil: Europe Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
8. Europe Vitamin K2 Market – Revenue and Forecast to 2030 – by Source.
8.1 Overview
8.2 Europe Vitamin K2 Market Revenue Share, by Source, 2022 & 2030 (%)
8.3 Natural
8.3.1 Overview
8.3.2 Natural: Europe Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Synthetic
8.4.1 Overview
8.4.2 Synthetic: Europe Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe Vitamin K2 Market – Revenue and Forecast to 2030 – by Application.
9.1 Overview
9.2 Europe Vitamin K2 Market Revenue Share, by Application, 2022 & 2030 (%)
9.3 Pharmaceuticals
9.3.1 Overview
9.3.2 Pharmaceuticals: Europe Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Nutraceuticals and Food
9.4.1 Overview
9.4.2 Nutraceuticals and Food: Europe Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Europe Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
10. Europe Vitamin K2 Market – Country Analysis
10.1.1 Europe Vitamin K2 Market by Country
10.1.1.1 Germany
10.1.1.1.1 Overview
10.1.1.1.2 Germany: Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.1.3 Germany: Europe Vitamin K2 Market, by Product
10.1.1.1.4 Germany: Europe Vitamin K2 Market, by Dosage Form
10.1.1.1.5 Germany: Europe Vitamin K2 Market, by Source
10.1.1.1.6 Germany: Europe Vitamin K2 Market, by Application
10.1.1.2 UK
10.1.1.2.1 Overview
10.1.1.2.2 UK: Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.3 UK: Europe Vitamin K2 Market, by Product
10.1.1.2.4 UK: Europe Vitamin K2 Market, by Dosage Form
10.1.1.2.5 UK: Europe Vitamin K2 Market, by Source
10.1.1.2.6 UK: Europe Vitamin K2 Market, by Application
10.1.1.3 France
10.1.1.3.1 Overview
10.1.1.3.2 France: Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.3 France: Europe Vitamin K2 Market, by Product
10.1.1.3.4 France: Europe Vitamin K2 Market, by Dosage Form
10.1.1.3.5 France: Europe Vitamin K2 Market, by Source
10.1.1.3.6 France: Europe Vitamin K2 Market, by Application
10.1.1.4 Italy
10.1.1.4.1 Overview
10.1.1.4.2 Italy: Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.3 Italy: Europe Vitamin K2 Market, by Product
10.1.1.4.4 Italy: Europe Vitamin K2 Market, by Dosage Form
10.1.1.4.5 Italy: Europe Vitamin K2 Market, by Source
10.1.1.4.6 Italy: Europe Vitamin K2 Market, by Application
10.1.1.5 Spain
10.1.1.5.1 Overview
10.1.1.5.2 Spain: Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.5.3 Spain: Europe Vitamin K2 Market, by Product
10.1.1.5.4 Spain: Europe Vitamin K2 Market, by Dosage Form
10.1.1.5.5 Spain: Europe Vitamin K2 Market, by Source
10.1.1.5.6 Spain: Europe Vitamin K2 Market, by Application
10.1.1.6 Rest of Europe
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe: Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.6.3 Rest of Europe: Europe Vitamin K2 Market, by Product
10.1.1.6.4 Rest of Europe: Europe Vitamin K2 Market, by Dosage Form
10.1.1.6.5 Rest of Europe: Europe Vitamin K2 Market, by Source
10.1.1.6.6 Rest of Europe: Europe Vitamin K2 Market, by Application
11. Vitamin K2 Market Industry Landscape
11.1 Overview
11.2 Growth Strategies in Vitamin K2 Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Lonza Group AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 International Flavors & Fragrances Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Balchem Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 BASF SE
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Lesaffre et Cie SA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Koninklijke DSM NV
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Novozymes AS
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Glanbia Plc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Anderson Global Group LLC
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Vitamin K2 Market Segmentation
Table 2. Germany: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 3. Germany: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Surgery
Table 4. Germany: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 5. Germany: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 6. UK: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 7. UK: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Surgery
Table 8. UK: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 9. UK: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 10. France: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 11. France: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Surgery
Table 12. France: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – End-User
Table 13. France: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 14. Italy: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 15. Italy: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Surgery
Table 16. Italy: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 17. Italy: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 18. Spain: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 19. Spain: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Surgery
Table 20. Spain: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 21. Spain: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 22. Rest of Europe: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 23. Rest of Europe: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Surgery
Table 24. Rest of Europe: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Source
Table 25. Rest of Europe: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 26. Recent Organic Growth Strategies in Vitamin K2 Market
Table 27. Recent Inorganic Growth Strategies in the Vitamin K2 Market
Table 28. Glossary of Terms, Europe Vitamin K2 Market
LIST OF FIGURES
Figure 1. Europe Vitamin K2 Market Segmentation, By Country
Figure 2. Europe Vitamin K2 Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Vitamin K2 Market Revenue (US$ Mn), 2022 – 2030
Figure 5. Europe Vitamin K2 Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. MK-4: Europe Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. MK-7: Europe Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Combination Drugs: Europe Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Europe Vitamin K2 Market Revenue Share, by Dosage Form 2022 & 2030 (%)
Figure 10. Capsules and Tablets: Europe Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Powder: Europe Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Oil: Europe Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Europe Vitamin K2 Market Revenue Share, by Source 2022 & 2030 (%)
Figure 14. Natural: Europe Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Synthetic: Europe Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Europe Vitamin K2 Market Revenue Share, by Application 2022 & 2030 (%)
Figure 17. Pharmaceuticals: Europe Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Nutraceuticals and Food: Europe Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Europe Vitamin K2 Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Europe Vitamin K2 Market, By Country, 2022 ($Mn)
Figure 21. Europe Vitamin K2 Market, By Key Countries, 2022 And 2030 (%)
Figure 22. AS is the most common valvular heart disease, with a dismal prognosis when untreated. Recommended therapy is SAVR or TAVR.
Figure 23. Germany: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 24. UK: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 25. France: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 26. Italy: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 27. Spain: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 28. Rest of Europe: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 29. Growth Strategies in Vitamin K2 Market
The List of Companies – Europe Vitamin K2 Market
1. Anderson Global Group LLC
2. Balchem Corp
3. BASF SE
4. Glanbia Plc
5. International Flavors & Fragrances Inc
6. Koninklijke DSM NV
7. Lesaffre et Cie SA
8. Lonza Group AG
9. Novozymes AS
You must be logged in to post a review.
Reviews
There are no reviews yet.